Global Low Molecular Weight Heparin (LMWHs) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 92

Published Date: 02 Jan 2024

Category: Chemical & Material

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Product Tags

Description

According to our (Global Info Research) latest study, the global Low Molecular Weight Heparin (LMWHs) market size was valued at USD 348.4 million in 2023 and is forecast to a readjusted size of USD 427.5 million by 2030 with a CAGR of 3.0% during review period.

Low Molecular Weight Heparin (LMWHs) is derived from UFH (Unfractionated heparin) by such processes as chemical degradation, enzymatic depolymerisation and gamma-radiation cleavage.

Natural heparin consists of molecular chains of varying lengths, or molecular weights. Chains of varying molecular weights, from 5000 to over 40,000 Daltons, make up polydisperse pharmaceutical-grade heparin. LMWHs, in contrast, consist of only short chains of polysaccharide. LMWHs are defined as heparin salts having an average molecular weight of less than 8000 Da and for which at least 60% of all chains have a molecular weight less than 8003 Da.

Global Low Molecular Weight Heparin main players are Aspen, Sanofi-aventis, CSBIO, Dongying Tiandong Pharmaceutical, Techdow, etc. Top five companies hold a share above 55%. Europe is the largest market, with a share about 38%.

The Global Info Research report includes an overview of the development of the Low Molecular Weight Heparin (LMWHs) industry chain, the market status of Treatment of Venous Thromboembolism (Enoxaparin, Dalteparin), Complications of Pregnancy (Enoxaparin, Dalteparin), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Low Molecular Weight Heparin (LMWHs).

Regionally, the report analyzes the Low Molecular Weight Heparin (LMWHs) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Low Molecular Weight Heparin (LMWHs) market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Low Molecular Weight Heparin (LMWHs) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Low Molecular Weight Heparin (LMWHs) industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Kiloton), revenue generated, and market share of different by Type (e.g., Enoxaparin, Dalteparin).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Low Molecular Weight Heparin (LMWHs) market.

Regional Analysis: The report involves examining the Low Molecular Weight Heparin (LMWHs) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Low Molecular Weight Heparin (LMWHs) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Low Molecular Weight Heparin (LMWHs):
Company Analysis: Report covers individual Low Molecular Weight Heparin (LMWHs) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Low Molecular Weight Heparin (LMWHs) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Treatment of Venous Thromboembolism, Complications of Pregnancy).

Technology Analysis: Report covers specific technologies relevant to Low Molecular Weight Heparin (LMWHs). It assesses the current state, advancements, and potential future developments in Low Molecular Weight Heparin (LMWHs) areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Low Molecular Weight Heparin (LMWHs) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Low Molecular Weight Heparin (LMWHs) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
Enoxaparin
Dalteparin
Tinzaparin
Fraxiparine

Market segment by Application
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Others

Major players covered
Aspen
Sanofi-aventis
Pfizer
Opocrin
CSBIO
Dongying Tiandong Pharmaceutical
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Low Molecular Weight Heparin (LMWHs) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Low Molecular Weight Heparin (LMWHs), with price, sales, revenue and global market share of Low Molecular Weight Heparin (LMWHs) from 2019 to 2024.
Chapter 3, the Low Molecular Weight Heparin (LMWHs) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Low Molecular Weight Heparin (LMWHs) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Low Molecular Weight Heparin (LMWHs) market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Low Molecular Weight Heparin (LMWHs).
Chapter 14 and 15, to describe Low Molecular Weight Heparin (LMWHs) sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Low Molecular Weight Heparin (LMWHs)
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Low Molecular Weight Heparin (LMWHs) Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Enoxaparin
        1.3.3 Dalteparin
        1.3.4 Tinzaparin
        1.3.5 Fraxiparine
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Low Molecular Weight Heparin (LMWHs) Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Treatment of Venous Thromboembolism
        1.4.3 Complications of Pregnancy
        1.4.4 Cardioversion of Atrial Fibrillation/Flutter
        1.4.5 Others
    1.5 Global Low Molecular Weight Heparin (LMWHs) Market Size & Forecast
        1.5.1 Global Low Molecular Weight Heparin (LMWHs) Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Low Molecular Weight Heparin (LMWHs) Sales Quantity (2019-2030)
        1.5.3 Global Low Molecular Weight Heparin (LMWHs) Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Aspen
        2.1.1 Aspen Details
        2.1.2 Aspen Major Business
        2.1.3 Aspen Low Molecular Weight Heparin (LMWHs) Product and Services
        2.1.4 Aspen Low Molecular Weight Heparin (LMWHs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Aspen Recent Developments/Updates
    2.2 Sanofi-aventis
        2.2.1 Sanofi-aventis Details
        2.2.2 Sanofi-aventis Major Business
        2.2.3 Sanofi-aventis Low Molecular Weight Heparin (LMWHs) Product and Services
        2.2.4 Sanofi-aventis Low Molecular Weight Heparin (LMWHs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Sanofi-aventis Recent Developments/Updates
    2.3 Pfizer
        2.3.1 Pfizer Details
        2.3.2 Pfizer Major Business
        2.3.3 Pfizer Low Molecular Weight Heparin (LMWHs) Product and Services
        2.3.4 Pfizer Low Molecular Weight Heparin (LMWHs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Pfizer Recent Developments/Updates
    2.4 Opocrin
        2.4.1 Opocrin Details
        2.4.2 Opocrin Major Business
        2.4.3 Opocrin Low Molecular Weight Heparin (LMWHs) Product and Services
        2.4.4 Opocrin Low Molecular Weight Heparin (LMWHs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Opocrin Recent Developments/Updates
    2.5 CSBIO
        2.5.1 CSBIO Details
        2.5.2 CSBIO Major Business
        2.5.3 CSBIO Low Molecular Weight Heparin (LMWHs) Product and Services
        2.5.4 CSBIO Low Molecular Weight Heparin (LMWHs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 CSBIO Recent Developments/Updates
    2.6 Dongying Tiandong Pharmaceutical
        2.6.1 Dongying Tiandong Pharmaceutical Details
        2.6.2 Dongying Tiandong Pharmaceutical Major Business
        2.6.3 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin (LMWHs) Product and Services
        2.6.4 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin (LMWHs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Dongying Tiandong Pharmaceutical Recent Developments/Updates
    2.7 Changzhou Qianhong Bio-pharma
        2.7.1 Changzhou Qianhong Bio-pharma Details
        2.7.2 Changzhou Qianhong Bio-pharma Major Business
        2.7.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin (LMWHs) Product and Services
        2.7.4 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin (LMWHs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Changzhou Qianhong Bio-pharma Recent Developments/Updates
    2.8 Techdow
        2.8.1 Techdow Details
        2.8.2 Techdow Major Business
        2.8.3 Techdow Low Molecular Weight Heparin (LMWHs) Product and Services
        2.8.4 Techdow Low Molecular Weight Heparin (LMWHs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Techdow Recent Developments/Updates
    2.9 Yantai Dongcheng Pharmaceutical Group
        2.9.1 Yantai Dongcheng Pharmaceutical Group Details
        2.9.2 Yantai Dongcheng Pharmaceutical Group Major Business
        2.9.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin (LMWHs) Product and Services
        2.9.4 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin (LMWHs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Yantai Dongcheng Pharmaceutical Group Recent Developments/Updates

3 Competitive Environment: Low Molecular Weight Heparin (LMWHs) by Manufacturer
    3.1 Global Low Molecular Weight Heparin (LMWHs) Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Low Molecular Weight Heparin (LMWHs) Revenue by Manufacturer (2019-2024)
    3.3 Global Low Molecular Weight Heparin (LMWHs) Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Low Molecular Weight Heparin (LMWHs) by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Low Molecular Weight Heparin (LMWHs) Manufacturer Market Share in 2023
        3.4.2 Top 6 Low Molecular Weight Heparin (LMWHs) Manufacturer Market Share in 2023
    3.5 Low Molecular Weight Heparin (LMWHs) Market: Overall Company Footprint Analysis
        3.5.1 Low Molecular Weight Heparin (LMWHs) Market: Region Footprint
        3.5.2 Low Molecular Weight Heparin (LMWHs) Market: Company Product Type Footprint
        3.5.3 Low Molecular Weight Heparin (LMWHs) Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Low Molecular Weight Heparin (LMWHs) Market Size by Region
        4.1.1 Global Low Molecular Weight Heparin (LMWHs) Sales Quantity by Region (2019-2030)
        4.1.2 Global Low Molecular Weight Heparin (LMWHs) Consumption Value by Region (2019-2030)
        4.1.3 Global Low Molecular Weight Heparin (LMWHs) Average Price by Region (2019-2030)
    4.2 North America Low Molecular Weight Heparin (LMWHs) Consumption Value (2019-2030)
    4.3 Europe Low Molecular Weight Heparin (LMWHs) Consumption Value (2019-2030)
    4.4 Asia-Pacific Low Molecular Weight Heparin (LMWHs) Consumption Value (2019-2030)
    4.5 South America Low Molecular Weight Heparin (LMWHs) Consumption Value (2019-2030)
    4.6 Middle East and Africa Low Molecular Weight Heparin (LMWHs) Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Low Molecular Weight Heparin (LMWHs) Sales Quantity by Type (2019-2030)
    5.2 Global Low Molecular Weight Heparin (LMWHs) Consumption Value by Type (2019-2030)
    5.3 Global Low Molecular Weight Heparin (LMWHs) Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Low Molecular Weight Heparin (LMWHs) Sales Quantity by Application (2019-2030)
    6.2 Global Low Molecular Weight Heparin (LMWHs) Consumption Value by Application (2019-2030)
    6.3 Global Low Molecular Weight Heparin (LMWHs) Average Price by Application (2019-2030)

7 North America
    7.1 North America Low Molecular Weight Heparin (LMWHs) Sales Quantity by Type (2019-2030)
    7.2 North America Low Molecular Weight Heparin (LMWHs) Sales Quantity by Application (2019-2030)
    7.3 North America Low Molecular Weight Heparin (LMWHs) Market Size by Country
        7.3.1 North America Low Molecular Weight Heparin (LMWHs) Sales Quantity by Country (2019-2030)
        7.3.2 North America Low Molecular Weight Heparin (LMWHs) Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Low Molecular Weight Heparin (LMWHs) Sales Quantity by Type (2019-2030)
    8.2 Europe Low Molecular Weight Heparin (LMWHs) Sales Quantity by Application (2019-2030)
    8.3 Europe Low Molecular Weight Heparin (LMWHs) Market Size by Country
        8.3.1 Europe Low Molecular Weight Heparin (LMWHs) Sales Quantity by Country (2019-2030)
        8.3.2 Europe Low Molecular Weight Heparin (LMWHs) Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Low Molecular Weight Heparin (LMWHs) Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Low Molecular Weight Heparin (LMWHs) Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Low Molecular Weight Heparin (LMWHs) Market Size by Region
        9.3.1 Asia-Pacific Low Molecular Weight Heparin (LMWHs) Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Low Molecular Weight Heparin (LMWHs) Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Low Molecular Weight Heparin (LMWHs) Sales Quantity by Type (2019-2030)
    10.2 South America Low Molecular Weight Heparin (LMWHs) Sales Quantity by Application (2019-2030)
    10.3 South America Low Molecular Weight Heparin (LMWHs) Market Size by Country
        10.3.1 South America Low Molecular Weight Heparin (LMWHs) Sales Quantity by Country (2019-2030)
        10.3.2 South America Low Molecular Weight Heparin (LMWHs) Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Low Molecular Weight Heparin (LMWHs) Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Low Molecular Weight Heparin (LMWHs) Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Low Molecular Weight Heparin (LMWHs) Market Size by Country
        11.3.1 Middle East & Africa Low Molecular Weight Heparin (LMWHs) Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Low Molecular Weight Heparin (LMWHs) Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Low Molecular Weight Heparin (LMWHs) Market Drivers
    12.2 Low Molecular Weight Heparin (LMWHs) Market Restraints
    12.3 Low Molecular Weight Heparin (LMWHs) Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Low Molecular Weight Heparin (LMWHs) and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Low Molecular Weight Heparin (LMWHs)
    13.3 Low Molecular Weight Heparin (LMWHs) Production Process
    13.4 Low Molecular Weight Heparin (LMWHs) Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Low Molecular Weight Heparin (LMWHs) Typical Distributors
    14.3 Low Molecular Weight Heparin (LMWHs) Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Low Molecular Weight Heparin (LMWHs) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Low Molecular Weight Heparin (LMWHs) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Aspen Basic Information, Manufacturing Base and Competitors
    Table 4. Aspen Major Business
    Table 5. Aspen Low Molecular Weight Heparin (LMWHs) Product and Services
    Table 6. Aspen Low Molecular Weight Heparin (LMWHs) Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. Aspen Recent Developments/Updates
    Table 8. Sanofi-aventis Basic Information, Manufacturing Base and Competitors
    Table 9. Sanofi-aventis Major Business
    Table 10. Sanofi-aventis Low Molecular Weight Heparin (LMWHs) Product and Services
    Table 11. Sanofi-aventis Low Molecular Weight Heparin (LMWHs) Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Sanofi-aventis Recent Developments/Updates
    Table 13. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 14. Pfizer Major Business
    Table 15. Pfizer Low Molecular Weight Heparin (LMWHs) Product and Services
    Table 16. Pfizer Low Molecular Weight Heparin (LMWHs) Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Pfizer Recent Developments/Updates
    Table 18. Opocrin Basic Information, Manufacturing Base and Competitors
    Table 19. Opocrin Major Business
    Table 20. Opocrin Low Molecular Weight Heparin (LMWHs) Product and Services
    Table 21. Opocrin Low Molecular Weight Heparin (LMWHs) Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Opocrin Recent Developments/Updates
    Table 23. CSBIO Basic Information, Manufacturing Base and Competitors
    Table 24. CSBIO Major Business
    Table 25. CSBIO Low Molecular Weight Heparin (LMWHs) Product and Services
    Table 26. CSBIO Low Molecular Weight Heparin (LMWHs) Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. CSBIO Recent Developments/Updates
    Table 28. Dongying Tiandong Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 29. Dongying Tiandong Pharmaceutical Major Business
    Table 30. Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin (LMWHs) Product and Services
    Table 31. Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin (LMWHs) Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. Dongying Tiandong Pharmaceutical Recent Developments/Updates
    Table 33. Changzhou Qianhong Bio-pharma Basic Information, Manufacturing Base and Competitors
    Table 34. Changzhou Qianhong Bio-pharma Major Business
    Table 35. Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin (LMWHs) Product and Services
    Table 36. Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin (LMWHs) Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. Changzhou Qianhong Bio-pharma Recent Developments/Updates
    Table 38. Techdow Basic Information, Manufacturing Base and Competitors
    Table 39. Techdow Major Business
    Table 40. Techdow Low Molecular Weight Heparin (LMWHs) Product and Services
    Table 41. Techdow Low Molecular Weight Heparin (LMWHs) Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 42. Techdow Recent Developments/Updates
    Table 43. Yantai Dongcheng Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
    Table 44. Yantai Dongcheng Pharmaceutical Group Major Business
    Table 45. Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin (LMWHs) Product and Services
    Table 46. Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin (LMWHs) Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 47. Yantai Dongcheng Pharmaceutical Group Recent Developments/Updates
    Table 48. Global Low Molecular Weight Heparin (LMWHs) Sales Quantity by Manufacturer (2019-2024) & (Kiloton)
    Table 49. Global Low Molecular Weight Heparin (LMWHs) Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 50. Global Low Molecular Weight Heparin (LMWHs) Average Price by Manufacturer (2019-2024) & (US$/Ton)
    Table 51. Market Position of Manufacturers in Low Molecular Weight Heparin (LMWHs), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 52. Head Office and Low Molecular Weight Heparin (LMWHs) Production Site of Key Manufacturer
    Table 53. Low Molecular Weight Heparin (LMWHs) Market: Company Product Type Footprint
    Table 54. Low Molecular Weight Heparin (LMWHs) Market: Company Product Application Footprint
    Table 55. Low Molecular Weight Heparin (LMWHs) New Market Entrants and Barriers to Market Entry
    Table 56. Low Molecular Weight Heparin (LMWHs) Mergers, Acquisition, Agreements, and Collaborations
    Table 57. Global Low Molecular Weight Heparin (LMWHs) Sales Quantity by Region (2019-2024) & (Kiloton)
    Table 58. Global Low Molecular Weight Heparin (LMWHs) Sales Quantity by Region (2025-2030) & (Kiloton)
    Table 59. Global Low Molecular Weight Heparin (LMWHs) Consumption Value by Region (2019-2024) & (USD Million)
    Table 60. Global Low Molecular Weight Heparin (LMWHs) Consumption Value by Region (2025-2030) & (USD Million)
    Table 61. Global Low Molecular Weight Heparin (LMWHs) Average Price by Region (2019-2024) & (US$/Ton)
    Table 62. Global Low Molecular Weight Heparin (LMWHs) Average Price by Region (2025-2030) & (US$/Ton)
    Table 63. Global Low Molecular Weight Heparin (LMWHs) Sales Quantity by Type (2019-2024) & (Kiloton)
    Table 64. Global Low Molecular Weight Heparin (LMWHs) Sales Quantity by Type (2025-2030) & (Kiloton)
    Table 65. Global Low Molecular Weight Heparin (LMWHs) Consumption Value by Type (2019-2024) & (USD Million)
    Table 66. Global Low Molecular Weight Heparin (LMWHs) Consumption Value by Type (2025-2030) & (USD Million)
    Table 67. Global Low Molecular Weight Heparin (LMWHs) Average Price by Type (2019-2024) & (US$/Ton)
    Table 68. Global Low Molecular Weight Heparin (LMWHs) Average Price by Type (2025-2030) & (US$/Ton)
    Table 69. Global Low Molecular Weight Heparin (LMWHs) Sales Quantity by Application (2019-2024) & (Kiloton)
    Table 70. Global Low Molecular Weight Heparin (LMWHs) Sales Quantity by Application (2025-2030) & (Kiloton)
    Table 71. Global Low Molecular Weight Heparin (LMWHs) Consumption Value by Application (2019-2024) & (USD Million)
    Table 72. Global Low Molecular Weight Heparin (LMWHs) Consumption Value by Application (2025-2030) & (USD Million)
    Table 73. Global Low Molecular Weight Heparin (LMWHs) Average Price by Application (2019-2024) & (US$/Ton)
    Table 74. Global Low Molecular Weight Heparin (LMWHs) Average Price by Application (2025-2030) & (US$/Ton)
    Table 75. North America Low Molecular Weight Heparin (LMWHs) Sales Quantity by Type (2019-2024) & (Kiloton)
    Table 76. North America Low Molecular Weight Heparin (LMWHs) Sales Quantity by Type (2025-2030) & (Kiloton)
    Table 77. North America Low Molecular Weight Heparin (LMWHs) Sales Quantity by Application (2019-2024) & (Kiloton)
    Table 78. North America Low Molecular Weight Heparin (LMWHs) Sales Quantity by Application (2025-2030) & (Kiloton)
    Table 79. North America Low Molecular Weight Heparin (LMWHs) Sales Quantity by Country (2019-2024) & (Kiloton)
    Table 80. North America Low Molecular Weight Heparin (LMWHs) Sales Quantity by Country (2025-2030) & (Kiloton)
    Table 81. North America Low Molecular Weight Heparin (LMWHs) Consumption Value by Country (2019-2024) & (USD Million)
    Table 82. North America Low Molecular Weight Heparin (LMWHs) Consumption Value by Country (2025-2030) & (USD Million)
    Table 83. Europe Low Molecular Weight Heparin (LMWHs) Sales Quantity by Type (2019-2024) & (Kiloton)
    Table 84. Europe Low Molecular Weight Heparin (LMWHs) Sales Quantity by Type (2025-2030) & (Kiloton)
    Table 85. Europe Low Molecular Weight Heparin (LMWHs) Sales Quantity by Application (2019-2024) & (Kiloton)
    Table 86. Europe Low Molecular Weight Heparin (LMWHs) Sales Quantity by Application (2025-2030) & (Kiloton)
    Table 87. Europe Low Molecular Weight Heparin (LMWHs) Sales Quantity by Country (2019-2024) & (Kiloton)
    Table 88. Europe Low Molecular Weight Heparin (LMWHs) Sales Quantity by Country (2025-2030) & (Kiloton)
    Table 89. Europe Low Molecular Weight Heparin (LMWHs) Consumption Value by Country (2019-2024) & (USD Million)
    Table 90. Europe Low Molecular Weight Heparin (LMWHs) Consumption Value by Country (2025-2030) & (USD Million)
    Table 91. Asia-Pacific Low Molecular Weight Heparin (LMWHs) Sales Quantity by Type (2019-2024) & (Kiloton)
    Table 92. Asia-Pacific Low Molecular Weight Heparin (LMWHs) Sales Quantity by Type (2025-2030) & (Kiloton)
    Table 93. Asia-Pacific Low Molecular Weight Heparin (LMWHs) Sales Quantity by Application (2019-2024) & (Kiloton)
    Table 94. Asia-Pacific Low Molecular Weight Heparin (LMWHs) Sales Quantity by Application (2025-2030) & (Kiloton)
    Table 95. Asia-Pacific Low Molecular Weight Heparin (LMWHs) Sales Quantity by Region (2019-2024) & (Kiloton)
    Table 96. Asia-Pacific Low Molecular Weight Heparin (LMWHs) Sales Quantity by Region (2025-2030) & (Kiloton)
    Table 97. Asia-Pacific Low Molecular Weight Heparin (LMWHs) Consumption Value by Region (2019-2024) & (USD Million)
    Table 98. Asia-Pacific Low Molecular Weight Heparin (LMWHs) Consumption Value by Region (2025-2030) & (USD Million)
    Table 99. South America Low Molecular Weight Heparin (LMWHs) Sales Quantity by Type (2019-2024) & (Kiloton)
    Table 100. South America Low Molecular Weight Heparin (LMWHs) Sales Quantity by Type (2025-2030) & (Kiloton)
    Table 101. South America Low Molecular Weight Heparin (LMWHs) Sales Quantity by Application (2019-2024) & (Kiloton)
    Table 102. South America Low Molecular Weight Heparin (LMWHs) Sales Quantity by Application (2025-2030) & (Kiloton)
    Table 103. South America Low Molecular Weight Heparin (LMWHs) Sales Quantity by Country (2019-2024) & (Kiloton)
    Table 104. South America Low Molecular Weight Heparin (LMWHs) Sales Quantity by Country (2025-2030) & (Kiloton)
    Table 105. South America Low Molecular Weight Heparin (LMWHs) Consumption Value by Country (2019-2024) & (USD Million)
    Table 106. South America Low Molecular Weight Heparin (LMWHs) Consumption Value by Country (2025-2030) & (USD Million)
    Table 107. Middle East & Africa Low Molecular Weight Heparin (LMWHs) Sales Quantity by Type (2019-2024) & (Kiloton)
    Table 108. Middle East & Africa Low Molecular Weight Heparin (LMWHs) Sales Quantity by Type (2025-2030) & (Kiloton)
    Table 109. Middle East & Africa Low Molecular Weight Heparin (LMWHs) Sales Quantity by Application (2019-2024) & (Kiloton)
    Table 110. Middle East & Africa Low Molecular Weight Heparin (LMWHs) Sales Quantity by Application (2025-2030) & (Kiloton)
    Table 111. Middle East & Africa Low Molecular Weight Heparin (LMWHs) Sales Quantity by Region (2019-2024) & (Kiloton)
    Table 112. Middle East & Africa Low Molecular Weight Heparin (LMWHs) Sales Quantity by Region (2025-2030) & (Kiloton)
    Table 113. Middle East & Africa Low Molecular Weight Heparin (LMWHs) Consumption Value by Region (2019-2024) & (USD Million)
    Table 114. Middle East & Africa Low Molecular Weight Heparin (LMWHs) Consumption Value by Region (2025-2030) & (USD Million)
    Table 115. Low Molecular Weight Heparin (LMWHs) Raw Material
    Table 116. Key Manufacturers of Low Molecular Weight Heparin (LMWHs) Raw Materials
    Table 117. Low Molecular Weight Heparin (LMWHs) Typical Distributors
    Table 118. Low Molecular Weight Heparin (LMWHs) Typical Customers
List of Figures
    Figure 1. Low Molecular Weight Heparin (LMWHs) Picture
    Figure 2. Global Low Molecular Weight Heparin (LMWHs) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Low Molecular Weight Heparin (LMWHs) Consumption Value Market Share by Type in 2023
    Figure 4. Enoxaparin Examples
    Figure 5. Dalteparin Examples
    Figure 6. Tinzaparin Examples
    Figure 7. Fraxiparine Examples
    Figure 8. Global Low Molecular Weight Heparin (LMWHs) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 9. Global Low Molecular Weight Heparin (LMWHs) Consumption Value Market Share by Application in 2023
    Figure 10. Treatment of Venous Thromboembolism Examples
    Figure 11. Complications of Pregnancy Examples
    Figure 12. Cardioversion of Atrial Fibrillation/Flutter Examples
    Figure 13. Others Examples
    Figure 14. Global Low Molecular Weight Heparin (LMWHs) Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 15. Global Low Molecular Weight Heparin (LMWHs) Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 16. Global Low Molecular Weight Heparin (LMWHs) Sales Quantity (2019-2030) & (Kiloton)
    Figure 17. Global Low Molecular Weight Heparin (LMWHs) Average Price (2019-2030) & (US$/Ton)
    Figure 18. Global Low Molecular Weight Heparin (LMWHs) Sales Quantity Market Share by Manufacturer in 2023
    Figure 19. Global Low Molecular Weight Heparin (LMWHs) Consumption Value Market Share by Manufacturer in 2023
    Figure 20. Producer Shipments of Low Molecular Weight Heparin (LMWHs) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 21. Top 3 Low Molecular Weight Heparin (LMWHs) Manufacturer (Consumption Value) Market Share in 2023
    Figure 22. Top 6 Low Molecular Weight Heparin (LMWHs) Manufacturer (Consumption Value) Market Share in 2023
    Figure 23. Global Low Molecular Weight Heparin (LMWHs) Sales Quantity Market Share by Region (2019-2030)
    Figure 24. Global Low Molecular Weight Heparin (LMWHs) Consumption Value Market Share by Region (2019-2030)
    Figure 25. North America Low Molecular Weight Heparin (LMWHs) Consumption Value (2019-2030) & (USD Million)
    Figure 26. Europe Low Molecular Weight Heparin (LMWHs) Consumption Value (2019-2030) & (USD Million)
    Figure 27. Asia-Pacific Low Molecular Weight Heparin (LMWHs) Consumption Value (2019-2030) & (USD Million)
    Figure 28. South America Low Molecular Weight Heparin (LMWHs) Consumption Value (2019-2030) & (USD Million)
    Figure 29. Middle East & Africa Low Molecular Weight Heparin (LMWHs) Consumption Value (2019-2030) & (USD Million)
    Figure 30. Global Low Molecular Weight Heparin (LMWHs) Sales Quantity Market Share by Type (2019-2030)
    Figure 31. Global Low Molecular Weight Heparin (LMWHs) Consumption Value Market Share by Type (2019-2030)
    Figure 32. Global Low Molecular Weight Heparin (LMWHs) Average Price by Type (2019-2030) & (US$/Ton)
    Figure 33. Global Low Molecular Weight Heparin (LMWHs) Sales Quantity Market Share by Application (2019-2030)
    Figure 34. Global Low Molecular Weight Heparin (LMWHs) Consumption Value Market Share by Application (2019-2030)
    Figure 35. Global Low Molecular Weight Heparin (LMWHs) Average Price by Application (2019-2030) & (US$/Ton)
    Figure 36. North America Low Molecular Weight Heparin (LMWHs) Sales Quantity Market Share by Type (2019-2030)
    Figure 37. North America Low Molecular Weight Heparin (LMWHs) Sales Quantity Market Share by Application (2019-2030)
    Figure 38. North America Low Molecular Weight Heparin (LMWHs) Sales Quantity Market Share by Country (2019-2030)
    Figure 39. North America Low Molecular Weight Heparin (LMWHs) Consumption Value Market Share by Country (2019-2030)
    Figure 40. United States Low Molecular Weight Heparin (LMWHs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 41. Canada Low Molecular Weight Heparin (LMWHs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 42. Mexico Low Molecular Weight Heparin (LMWHs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 43. Europe Low Molecular Weight Heparin (LMWHs) Sales Quantity Market Share by Type (2019-2030)
    Figure 44. Europe Low Molecular Weight Heparin (LMWHs) Sales Quantity Market Share by Application (2019-2030)
    Figure 45. Europe Low Molecular Weight Heparin (LMWHs) Sales Quantity Market Share by Country (2019-2030)
    Figure 46. Europe Low Molecular Weight Heparin (LMWHs) Consumption Value Market Share by Country (2019-2030)
    Figure 47. Germany Low Molecular Weight Heparin (LMWHs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. France Low Molecular Weight Heparin (LMWHs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 49. United Kingdom Low Molecular Weight Heparin (LMWHs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 50. Russia Low Molecular Weight Heparin (LMWHs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 51. Italy Low Molecular Weight Heparin (LMWHs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 52. Asia-Pacific Low Molecular Weight Heparin (LMWHs) Sales Quantity Market Share by Type (2019-2030)
    Figure 53. Asia-Pacific Low Molecular Weight Heparin (LMWHs) Sales Quantity Market Share by Application (2019-2030)
    Figure 54. Asia-Pacific Low Molecular Weight Heparin (LMWHs) Sales Quantity Market Share by Region (2019-2030)
    Figure 55. Asia-Pacific Low Molecular Weight Heparin (LMWHs) Consumption Value Market Share by Region (2019-2030)
    Figure 56. China Low Molecular Weight Heparin (LMWHs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. Japan Low Molecular Weight Heparin (LMWHs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. Korea Low Molecular Weight Heparin (LMWHs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 59. India Low Molecular Weight Heparin (LMWHs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 60. Southeast Asia Low Molecular Weight Heparin (LMWHs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 61. Australia Low Molecular Weight Heparin (LMWHs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 62. South America Low Molecular Weight Heparin (LMWHs) Sales Quantity Market Share by Type (2019-2030)
    Figure 63. South America Low Molecular Weight Heparin (LMWHs) Sales Quantity Market Share by Application (2019-2030)
    Figure 64. South America Low Molecular Weight Heparin (LMWHs) Sales Quantity Market Share by Country (2019-2030)
    Figure 65. South America Low Molecular Weight Heparin (LMWHs) Consumption Value Market Share by Country (2019-2030)
    Figure 66. Brazil Low Molecular Weight Heparin (LMWHs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 67. Argentina Low Molecular Weight Heparin (LMWHs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 68. Middle East & Africa Low Molecular Weight Heparin (LMWHs) Sales Quantity Market Share by Type (2019-2030)
    Figure 69. Middle East & Africa Low Molecular Weight Heparin (LMWHs) Sales Quantity Market Share by Application (2019-2030)
    Figure 70. Middle East & Africa Low Molecular Weight Heparin (LMWHs) Sales Quantity Market Share by Region (2019-2030)
    Figure 71. Middle East & Africa Low Molecular Weight Heparin (LMWHs) Consumption Value Market Share by Region (2019-2030)
    Figure 72. Turkey Low Molecular Weight Heparin (LMWHs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 73. Egypt Low Molecular Weight Heparin (LMWHs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 74. Saudi Arabia Low Molecular Weight Heparin (LMWHs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 75. South Africa Low Molecular Weight Heparin (LMWHs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 76. Low Molecular Weight Heparin (LMWHs) Market Drivers
    Figure 77. Low Molecular Weight Heparin (LMWHs) Market Restraints
    Figure 78. Low Molecular Weight Heparin (LMWHs) Market Trends
    Figure 79. Porters Five Forces Analysis
    Figure 80. Manufacturing Cost Structure Analysis of Low Molecular Weight Heparin (LMWHs) in 2023
    Figure 81. Manufacturing Process Analysis of Low Molecular Weight Heparin (LMWHs)
    Figure 82. Low Molecular Weight Heparin (LMWHs) Industrial Chain
    Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 84. Direct Channel Pros & Cons
    Figure 85. Indirect Channel Pros & Cons
    Figure 86. Methodology
    Figure 87. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Aspen
Sanofi-aventis
Pfizer
Opocrin
CSBIO
Dongying Tiandong Pharmaceutical
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group

Product Tags

Low Molecular Weight Heparin (LMWHs)

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>